Submit Deal

TILRAY INC

Summary

Tilray operates as a pharmaceutical company. The Company develops cannabis based medicines, drugs, drops, and oil products. Tilray serves clients worldwide.

Deals Overview

Total Deals5

Valued Deals3

Total Value£ 3.23 B

Avg. Deal Size£ 1.08 B

Market Context

Senior Management

Brendan Kennedy
President and CEO
Irwin D. Simon
CEO
Mark Castaneda
CFO

Sort

20 Feb 2019|Canada|Food Products

Target: MANITOBA HARVEST

Bidder: TILRAY INC

8 Service Providers

1 Target | 5 Bidder | 2 Vendor

4 Dealmakers

1 Target | 3 Bidder

£ 243 M

Value

10 Jun 2019|Canada|Farming Fishing Ranching and Plantations

Target: TILRAY INC

Bidder: PRIVATEER INC

4 Service Providers

3 Target | 1 Bidder

11 Dealmakers

10 Target | 1 Bidder

n/a

Value

29 Aug 2019|United States|Pharmaceuticals

Target: FOUR20

Bidder: TILRAY INC

1 Service Providers

1 Bidder

1 Dealmakers

1 Bidder

£ 67 M

Value

15 Dec 2020|Canada|Farming Fishing Ranching and Plantations

Target: TILRAY INC

Bidder: APHRIA INC

12 Service Providers

7 Target | 5 Bidder

77 Dealmakers

45 Target | 32 Bidder

£ 2.92 B

Value

08 Dec 2021|United States|Distillers and Vintners

Target: BRECKENRIDGE DISTILLERY

Bidder: TILRAY INC

3 Service Providers

1 Target | 2 Bidder

5 Dealmakers

1 Target | 4 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Senior Management

Brendan Kennedy
President and CEO
Irwin D. Simon
CEO
Mark Castaneda
CFO